Hexima Limited has released a shareholder announcement with updates on the following:
  • Lodgment of Prospectus with ASIC
  • Management and Board of Director Changes 
  • First Patient Treated in Phase IIb Clinical Trial 

View full announcement (pdf)
Hexima Limited Prospectus (pdf)